Until now, only two strategies are used to provide symptomatic relief to AD patients: acetylcholinesterase inhibitors, to maintain the level of acetylcholine in the brain, and N-methyl-D-aspartate receptor antagonists, to prevent excitotoxicity [59]. The gene discussed is ACHE; the disease is Alzheimer disease.